Crumpton v. Walgreen Co.

CourtAppellate Court of Illinois
DecidedJune 29, 2007
Docket1-06-0734 Rel
StatusPublished

This text of Crumpton v. Walgreen Co. (Crumpton v. Walgreen Co.) is published on Counsel Stack Legal Research, covering Appellate Court of Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Crumpton v. Walgreen Co., (Ill. Ct. App. 2007).

Opinion

FOURTH DIVISION June 29, 2007

No. 1-06-0734

JOANN CRUMPTON, as Special Administrator of ) Appeal from the Estate of Christina Crumpton, Deceased, ) the Circuit Court ) Of Cook County. Plaintiff-Appellant, ) ) v. ) ) WALGREEN COMPANY, a Corporation, ) ) Honorable Defendant-Appellee. ) Deborah M. Dooling, ) Judge Presiding.

PRESIDING JUSTICE QUINN delivered the opinion of the court:

Plaintiff Joann Crumpton filed a wrongful death and survival action against defendant

Walgreen Co. (Walgreens) following the death of her daughter, Christina. Following a trial, on

October 13, 2005, the jury returned a verdict in favor of plaintiff for $875,000 and also signed a

special interrogatory finding that plaintiff was 25% contributorily negligent in her daughter’s

death. Plaintiff appeals from orders of the circuit court granting Walgreens’ motion for judgment

notwithstanding the verdict (judgment n.o.v.) and denying plaintiff’s posttrial motion to vacate the

jury’s special finding that plaintiff was 25% contributorily negligent in this case. Plaintiff also

appeals from the circuit court’s order denying plaintiff’s supplemental post-trial motion to vacate

the court’s order entering judgment n.o.v., to vacate the special finding that plaintiff was

contributorily negligent, and to grant plaintiff a new trial. For the following reasons, we affirm. 1-06-0734

I. Background

This case involves the death of plaintiff’s daughter, Christina, a 12- year-old girl who had

a history of psychosis. Christina was under the care and treatment of a number of psychiatrists

and mental health professionals at various hospitals, including Riveredge Hospital. Christina was

placed on an antipsychotic medication called Risperal. On September 2, 2002, plaintiff filled the

prescription for Risperal at Walgreens.

The prescription for Risperal was for 90 pills, a 30-day supply, but plaintiff ran out of pills

for Christina after 10 days, on September 12, 2002. Plaintiff testified that she did not notice that

the pills were about to run out until there was only one pill remaining. Plaintiff testified that she

attempted to use the automated Walgreens system to refill the prescription, but was not

successful. Plaintiff then went to Walgreens and told the individual at the pharmacy that she had

not received all of the 90 pills for the prescription. Plaintiff testified that the pharmacist told her

that the computer indicated that the prescription had been properly filled and that plaintiff would

need to call her doctor.

Plaintiff testified that she called Christina’s therapist, Denise Hall, at Pro Care, as well as

Christina’s doctor, Dr. Khadija Khan, at Riveredge Hospital. Dr. Kahn returned plaintiff’s call the

next day, September 13, 2002, and indicated that she would call Walgreens regarding Christina’s

prescription. Plaintiff testified that when she called Walgreens, she was told that the doctor did

not call in a prescription for Christina. Plaintiff testified that Christina did not take her medication

from September 12 until September 16, 2002. Plaintiff testified that during this time Christina

“acted like a normal child.” Plaintiff testified that she slept with Christina at night because she

-2- 1-06-0734

was concerned that Christina did not have her medication. Plaintiff testified that if she had

noticed anything out of the ordinary about Christina, plaintiff would have taken Christina to the

emergency room.

Plaintiff testified that on September 16, 2002, she took Christina to see Dr. Martha

Zuelke, who wrote another prescription for Risperdal. Plaintiff testified that she filled the

prescription at Walgreens on September 16, 2002, and Christina began taking pills again that

evening. On September 17, 2002, plaintiff kept Christina home from school because she had

started taking Risperdal again and plaintiff was told to monitor Christina for drowsiness.

Christina spent the day with plaintiff and her baby brother. They had gone to Christina’s father’s

place of employment for lunch, stopped for ice cream, and returned home. At some point after

returning home, plaintiff asked Christina to straighten her bed. Christina went to her room and

the next time plaintiff saw Christina she was hanging from the top of her bunk bed with a jump

rope tied around her neck. Christina later died at the hospital.

Plaintiff testified that on September 22, 2002, she returned to Walgreens to determine if

she had been shorted pills when the original prescription had been filled. Plaintiff testified that

two technicians at Walgreens checked Christina’s patient profile and informed plaintiff that the

correct number of pills had been originally dispensed. Plaintiff then spoke with Dawn Stefek, a

registered pharmacist, who gave plaintiff an additional 60 pills of Risperdal and a note, included in

plaintiff’s exhibits, stating “For Christina Crumpton [sic] We gave her 60 more Risperdal 0.25 mg

on 9-23-02. It is possible we did not give her enough on 9-2-02.”

Plaintiff’s expert, Dr. Alex John Spadoni, a board-certified psychiatrist, testified regarding

-3- 1-06-0734

the nature of Christina’s illness and the therapeutic effects that Risperdal had on Christina’s

illness. Dr. Spadoni testified that in his opinion, the dosage of Risperdal prescribed for Christina

at Riveredge was appropriate because she showed remarkable improvement on it and tolerated it

well with little side effects. Dr. Spadoni testified that in his opinion, Christina’s suicide was

causally related to not taking the Risperdal medication from September 12 to September 16,

2002. Dr. Spadoni testified that if Christina had continued taking the dosage of Risperdal as

prescribed she would not have committed suicide. Dr. Spadoni also testified that Christina was

showing a breakthrough symptom on September 11, 2002, when she went to her school nurse

complaining of hallucinations. Dr. Spadoni testified that these breakthrough symptoms would

indicate that the medication should not be changed, but perhaps increased.

Dr. Spadoni also testified that he did not feel that there were sufficient grounds to

conclude that Christina was a danger to herself or anybody else to justify hospitalization when she

saw Dr. Zuelke on September 16, 2002. Dr. Spadoni testified that according to everyone

involved, Christina’s overt behavior was not psychotic. Dr. Spadoni also testified that the fact

that Christina committed suicide was not foreseeable to her psychiatrist and that he would not

expect a pharmacist to foresee that Christina was at risk for suicide. Dr. Spadoni testified as

follows:

“Q. However, the fact that this child committed suicide, that was not foreseeable

to the psychiatrist, was it?

A. It was not.

Q. If anyone is going to be able to foresee it, a psychiatrist is the person who is

-4- 1-06-0734

best trained to be able to foresee it?

A. True.

Q. So, if it wasn’t foreseeable to the psychiatrist, would you agree with me that it

would not have been foreseeable to anyone at Walgreens?

A. At Walgreens? I don’t quite understand the connection.

Q. If a psychiatrist could not foresee that this child was going to commit suicide,

one day after she saw Dr. Zuelke, would you expect Walgreens to have considered

her to be a suicide risk?

A. Walgreens?

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Moss v. Meyer
454 N.E.2d 48 (Appellate Court of Illinois, 1983)
Stasiof v. Chicago Hoist & Body Co., Inc.
200 N.E.2d 88 (Appellate Court of Illinois, 1964)
Repinski v. Jubilee Oil Co.
405 N.E.2d 1383 (Appellate Court of Illinois, 1980)
Suwanski v. Village of Lombard
794 N.E.2d 1016 (Appellate Court of Illinois, 2003)
Moss v. Amira
826 N.E.2d 1001 (Appellate Court of Illinois, 2005)
Chalhoub v. Dixon
788 N.E.2d 164 (Appellate Court of Illinois, 2003)
Hooper v. County of Cook
851 N.E.2d 663 (Appellate Court of Illinois, 2006)
Pempek v. Silliker Laboratories, Inc.
723 N.E.2d 803 (Appellate Court of Illinois, 1999)
Little v. Chicago Hoist & Body Co.
203 N.E.2d 902 (Illinois Supreme Court, 1965)
Washington v. City of Chicago
720 N.E.2d 1030 (Illinois Supreme Court, 1999)
McDonnell v. McPartlin
736 N.E.2d 1074 (Illinois Supreme Court, 2000)

Cite This Page — Counsel Stack

Bluebook (online)
Crumpton v. Walgreen Co., Counsel Stack Legal Research, https://law.counselstack.com/opinion/crumpton-v-walgreen-co-illappct-2007.